title: Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases.
authors.forename: T
authors.initials: T
authors.lastname: Glück
authors.forename: H-J
authors.initials: HJ
authors.lastname: Linde
authors.forename: J
authors.initials: J
authors.lastname: Schölmerich
authors.forename: U
authors.initials: U
authors.lastname: Müller-Ladner
authors.forename: C
authors.initials: C
authors.lastname: Fiehn
authors.forename: P
authors.initials: P
authors.lastname: Bohland
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D002764:Cholecystitis / Q000209:etiology / Q000473:pathology; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000276:immunology*; D000069285:Infliximab; D008089:Listeria monocytogenes / Q000302:isolation & purification* / Q000472:pathogenicity; D008088:Listeriosis / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab